Glenmede Trust CO Na Glaukos Corp Transaction History

Glenmede Trust CO Na

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$48.9 - $75.26 $41,467 - $63,820	-848 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$37.23 - $50.97 $632 - $866	17 Added 2.05%	848 $41,000
Q2 2020 Aug 14, 2020	BUY	$28.78 - $46.83 $16,893 - $27,489	587 Added 240.57%	831 $31,000
Q1 2019 May 14, 2019	BUY	$50.75 - $80.54 $964 - $1,530	19 Added 8.44%	244 $19,000
Q2 2018 Aug 15, 2018	SELL	$27.62 - $44.51 $12,567 - $20,252	-455 Reduced 66.91%	225 $9,000
Q4 2017 Feb 15, 2018	SELL	$24.5 - $36.01 $181,765 - $267,158	-7,419 Reduced 91.6%	680 $17,000
Q3 2017 Nov 14, 2017	BUY	$31.26 - $42.03 $253,174 - $340,400	8,099	8,099 $0

345

46.7M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.63B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.